Duet
Head of Payor Partnerships
New York City, Remote. Posted a month ago
The role
The Head of Payor Partnerships will lead health plan and payor relationships. This person will manage market strategy, outreach, contract negotiation, and implementation to scale value-based partnerships.
What you will do
- Lead identification, negotiation, and implementation of strategic partnerships with commercial and government payors.
- Develop and maintain strong, collaborative relationships with payor stakeholders.
- Build and execute a comprehensive prospecting strategy.
- Align Duet's capabilities with the strategic goals of potential partners.
- Own the contracting pipeline including scoping, negotiations, review, and implementation.
- Provide feedback loops on performance and value-add to stakeholders.
- Create and maintain market-specific payor models.
- Prepare and execute negotiation strategies including term sheet creation and financial modeling.
- Lead review and redlining of contract language through to execution.
- Use CRM to track activity, market insights, and progress.
Required qualifications
- 4-6 years of experience in healthcare, ideally in an external-facing role with a focus on payor relations, business development, or health plan or provider network management.
- Demonstrated experience with value-based care contracting.
- Proven ability to lead negotiations, draft proposals, and present complex partnership strategies to C-level audiences.
- Strong project management skills and ability to lead cross-functional initiatives to completion.
- Highly organized, detail-oriented, and adept at juggling multiple workstreams and deadlines.
- Self-starter with a bias toward action.
- Willingness to travel monthly for conferences and partner meetings.
Nice to have
- Proficiency in data modeling, contract performance analysis, and market intelligence gathering
About the company
Duet helps nurse-practitioners build and scale independent practices in underserved communities. The company is a well-funded, early-stage company backed by investors including Lerer Hippeau and Kairos.